PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β-Alanine, N-coco alkyl derivs., sodium salts | 271-795-1 | 68608-68-4 | - | - | - | - | 1 | - | - | - | - | Details |
| β-Alanine, N-coco alkyl derivs. | 284-219-9 | 84812-94-2 | - | - | - | - | 1 | - | - | - | - | Details |
| β-Alanine, N-C8-18-alkyl derivs., monopotassium salts | 290-475-2 | 90170-42-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
| β-Alanine, N-(2-carboxyethyl)-, N-coco alkyl derivs., disodium salts | 290-476-8 | 90170-43-7 | - | - | 1 | - | 1 | - | - | - | - | Details |
| β-Alanine, N-(2-aminoethyl)-N-(2-hydroxyethyl)-, N-coco acyl derivs., monosodium salts | 298-632-7 | 93820-52-1 | - | - | - | - | 1 | - | - | - | - | Details |
| α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol | 259-537-6 | 55219-65-3 | - | - | - | - | - | 2 | - | - | - | Details |
| α-methyl-1,3-benzodioxole-5-propionaldehyde | 214-881-6 | 1205-17-0 | - | - | 2 | - | - | 1 | - | - | - | Details |
| α-D-glucose | 207-757-8 | 492-62-6 | - | - | - | - | 1 | - | - | - | - | Details |
| α-D-Glucopyranoside, 2-ethylhexyl | 603-082-1 | 125590-73-0 | - | - | - | - | 1 | - | - | - | - | Details |
| α-D-Glucopyranose | 607-980-4 | 26655-34-5 | - | - | - | - | 1 | - | - | - | - | Details |